Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial
German biotech Adrenomed reports that its first-in-class antibody drug adrecizumab was well-tolerated by septic shock…
24/02/2020 - 3 minutes
Trends & News
Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies
The German biotech Immatics will partner with GSK and could receive more than €1B from…
20/02/2020 - 3 minutes
Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper
An equity investment worth up to €50M will push to market Univercells’ manufacturing technology, which…
19/02/2020 - 2 minutes
OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology
Belgian biotech OncoDNA has raised €19M in Series B funding to further develop its cancer…
18/02/2020 - 2 minutes
UK Biotech Closes €50M Series A for GPCR Drug Discovery
Oxford-based OMass Therapeutics has extended its Series A round by €33M to fund the spectrometry-assisted…
17/02/2020 - 2 minutes
Italian Investment Firm AurorA Science Launches to Support Early Stage Biotechs
Italian technology transfer company AurorA-TT has joined forces with drug discovery companies Rottapharm Biotech and…
14/02/2020 - 2 minutes
Novozymes Launches Super Robust Yeast to Maximize Biofuel Production
The Danish industrial biotech company Novozymes has announced the launch of its latest non-GM yeast…
14/02/2020 - 3 minutes
French Partnership Deploys AI for Antibody Drug Discovery
French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new…
13/02/2020 - 2 minutes
UK-Swiss Collaboration to Boost Biotech Profits with Automation
A partnership between the UK lab automation company Arctoris and Swiss software firm Molecule aims…
13/02/2020 - 3 minutes
Charcoal-Based Treatment Can Protect Gut Microbiome from Antibiotics
Ingestible pellets containing a charcoal-like treatment -- designed by the French company Da Volterra --…
12/02/2020 - 2 minutes
French Biotech Raises €20M to Make Precision Molecular Diagnostics
Stilla Technologies has raised a €20M Series C round to fund its mission to produce…
11/02/2020 - 2 minutes
First-in-Class Drug For Inherited Metabolic Diseases Funded with €25M
The Dutch startup Azafaros has raised €25M in Series A funding to push its drug…
10/02/2020 - 2 minutes
